Evidence supporting the use of: Anti-aromatase
For the health condition: Breasts (swelling and tenderness)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Anti-aromatase agents are scientifically validated for use in treating breast swelling and tenderness, particularly when these symptoms are related to hormone-sensitive conditions. Aromatase is the enzyme responsible for converting androgens to estrogens in the body. In some individuals, elevated estrogen levels can lead to gynecomastia (the development of breast tissue in males), as well as breast swelling and tenderness in both men and women, especially as a side effect of certain medications or hormone therapies.

Selective aromatase inhibitors such as anastrozole, letrozole, and exemestane are commonly prescribed in clinical settings. In men, they are used off-label to manage gynecomastia and breast tenderness caused by anabolic steroid use or certain medical treatments. In women, especially those with hormone receptor-positive breast cancer, anti-aromatase medications are used to decrease estrogen production, thus reducing the risk of cancer recurrence and alleviating symptoms related to excess estrogen, such as breast pain and swelling.

Multiple clinical trials and systematic reviews support the efficacy of aromatase inhibitors for reducing breast swelling and tenderness, particularly in the context of gynecomastia and breast cancer therapy. However, their use should be closely monitored by healthcare professionals due to potential side effects, such as bone density loss and cardiovascular risks. Overall, the scientific evidence supporting anti-aromatase agents for breast-related symptoms is strong in specific, clinically indicated populations.

More about Anti-aromatase
More about Breasts (swelling and tenderness)

Products containing Anti-aromatase

We currently have no products on Vitabase that contain this ingredient.